Research libraryMOLEKUL / SOURCE RECORD

Use of the new psychotropic preparation Bemitil in treating asthenic disorders

Iu. A. Aleksandrovskii, Iu. G. Bobkov, G. G. Neznamov, T. V. Serebriakova, S. S. Boiko · 1988 · Zh Nevropatol Psikhiatr Im S S Korsakova. 88(3):109–115. PMID 3381606

Human comparative studyEnglish abstractSource linked

This is Molekul’s research summary, not the original publication. Educational information only, not medical advice. Seek qualified healthcare help for medical conditions.

What does this source report?

Compared Bemitil with piracetam and pyrithioxine. The authors report earlier and greater changes in asthenic symptoms with Bemitil.

Population and setting: 130 patients with asthenic conditions related to neuropsychiatric disturbances
Evidence type: Human comparative study
Preparation: See the original report; formulation details require verification.
Source language: Russian
Title provenance: Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.

What are the limitations?

Randomization, blinding, arm sizes and effect estimates are not established from the abstract.
Historical diagnostic categories do not necessarily correspond to current diagnoses.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Source access and review scope

Indexed citation and abstract checked; full methods and risk of bias remain unreviewed.

Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.

Open original source or index record ↗

Cite and trace this record

Original source: Iu. A. Aleksandrovskii, Iu. G. Bobkov, G. G. Neznamov, T. V. Serebriakova, S. S. Boiko. Use of the new psychotropic preparation Bemitil in treating asthenic disorders Zh Nevropatol Psikhiatr Im S S Korsakova. 88(3):109–115. PMID 3381606 1988.

Molekul research summary: https://molekul.io/research/acto-3381606. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Bemitil

A benzimidazole-derived actoprotector, also indexed as bemethyl and Metaprot. Research spans patient asthenia, occupational settings, neuromuscular and liver studies, metabolism and preclinical safety; these are research contexts, not established uses.

Editorial policy and evidence standards